nodes	percent_of_prediction	percent_of_DWPC	metapath
Miglustat—GBA2—prostate gland—prostate cancer	0.0242	0.113	CbGeAlD
Miglustat—UGCG—prostate gland—prostate cancer	0.0238	0.111	CbGeAlD
Miglustat—GBA2—seminal vesicle—prostate cancer	0.0205	0.0952	CbGeAlD
Miglustat—UGCG—seminal vesicle—prostate cancer	0.0202	0.0939	CbGeAlD
Miglustat—GBA2—renal system—prostate cancer	0.0165	0.0767	CbGeAlD
Miglustat—UGCG—renal system—prostate cancer	0.0163	0.0757	CbGeAlD
Miglustat—GBA2—urethra—prostate cancer	0.0162	0.0754	CbGeAlD
Miglustat—UGCG—urethra—prostate cancer	0.016	0.0743	CbGeAlD
Miglustat—GBA2—bone marrow—prostate cancer	0.0125	0.058	CbGeAlD
Miglustat—UGCG—bone marrow—prostate cancer	0.0123	0.0572	CbGeAlD
Miglustat—GBA2—testis—prostate cancer	0.0107	0.0496	CbGeAlD
Miglustat—UGCG—testis—prostate cancer	0.0105	0.0489	CbGeAlD
Miglustat—GBA2—lymph node—prostate cancer	0.00772	0.036	CbGeAlD
Miglustat—UGCG—lymph node—prostate cancer	0.00761	0.0354	CbGeAlD
Miglustat—UGCG—Metabolism—PSAT1—prostate cancer	0.00116	0.00394	CbGpPWpGaD
Miglustat—UGCG—Metabolism—CSAD—prostate cancer	0.00116	0.00394	CbGpPWpGaD
Miglustat—UGCG—Metabolism—TST—prostate cancer	0.00116	0.00394	CbGpPWpGaD
Miglustat—UGCG—Metabolism—GRHL1—prostate cancer	0.00116	0.00394	CbGpPWpGaD
Miglustat—UGCG—Metabolism—CBR1—prostate cancer	0.00116	0.00394	CbGpPWpGaD
Miglustat—UGCG—Metabolism—ADI1—prostate cancer	0.00116	0.00394	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	0.00116	0.00391	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—MED12—prostate cancer	0.00114	0.00385	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	0.00114	0.00385	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	0.00112	0.00377	CbGpPWpGaD
Miglustat—GBA2—Metabolism—SULT2B1—prostate cancer	0.00111	0.00376	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PGAM2—prostate cancer	0.00111	0.00376	CbGpPWpGaD
Miglustat—GBA2—Metabolism—MBTPS1—prostate cancer	0.00111	0.00376	CbGpPWpGaD
Miglustat—GBA2—Metabolism—GSTM3—prostate cancer	0.00111	0.00376	CbGpPWpGaD
Miglustat—GBA2—Metabolism—NAGLU—prostate cancer	0.00111	0.00376	CbGpPWpGaD
Miglustat—GBA2—Metabolism—RFK—prostate cancer	0.00111	0.00376	CbGpPWpGaD
Miglustat—GBA2—Metabolism—AOX1—prostate cancer	0.00111	0.00376	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	0.00109	0.00368	CbGpPWpGaD
Miglustat—UGCG—Metabolism—UGT2B17—prostate cancer	0.00108	0.00366	CbGpPWpGaD
Miglustat—UGCG—Metabolism—UGT2B15—prostate cancer	0.00108	0.00366	CbGpPWpGaD
Miglustat—UGCG—Metabolism—CKMT2—prostate cancer	0.00108	0.00366	CbGpPWpGaD
Miglustat—UGCG—Metabolism—GRHPR—prostate cancer	0.00108	0.00366	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	0.00106	0.00358	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CYP3A43—prostate cancer	0.00106	0.00357	CbGpPWpGaD
Miglustat—GBA2—Metabolism—AMACR—prostate cancer	0.00106	0.00357	CbGpPWpGaD
Miglustat—GBA2—Metabolism—DEGS1—prostate cancer	0.00106	0.00357	CbGpPWpGaD
Miglustat—GBA2—Metabolism—NAT1—prostate cancer	0.00106	0.00357	CbGpPWpGaD
Miglustat—GBA2—Metabolism—SRD5A2—prostate cancer	0.00106	0.00357	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—MED12—prostate cancer	0.00104	0.00352	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	0.00104	0.00351	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	0.00103	0.00349	CbGpPWpGaD
Miglustat—UGCG—Metabolism—NAGLU—prostate cancer	0.00102	0.00344	CbGpPWpGaD
Miglustat—UGCG—Metabolism—GSTM3—prostate cancer	0.00102	0.00344	CbGpPWpGaD
Miglustat—UGCG—Metabolism—AOX1—prostate cancer	0.00102	0.00344	CbGpPWpGaD
Miglustat—UGCG—Metabolism—SULT2B1—prostate cancer	0.00102	0.00344	CbGpPWpGaD
Miglustat—UGCG—Metabolism—RFK—prostate cancer	0.00102	0.00344	CbGpPWpGaD
Miglustat—UGCG—Metabolism—MBTPS1—prostate cancer	0.00102	0.00344	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PGAM2—prostate cancer	0.00102	0.00344	CbGpPWpGaD
Miglustat—GBA2—Metabolism—HSD17B1—prostate cancer	0.00101	0.0034	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	0.00101	0.0034	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	0.000995	0.00336	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	0.000968	0.00327	CbGpPWpGaD
Miglustat—UGCG—Metabolism—AMACR—prostate cancer	0.000965	0.00326	CbGpPWpGaD
Miglustat—UGCG—Metabolism—CYP3A43—prostate cancer	0.000965	0.00326	CbGpPWpGaD
Miglustat—UGCG—Metabolism—NAT1—prostate cancer	0.000965	0.00326	CbGpPWpGaD
Miglustat—UGCG—Metabolism—SRD5A2—prostate cancer	0.000965	0.00326	CbGpPWpGaD
Miglustat—UGCG—Metabolism—DEGS1—prostate cancer	0.000965	0.00326	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	0.000963	0.00325	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	0.000953	0.00322	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	0.000949	0.00321	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	0.000943	0.00319	CbGpPWpGaD
Miglustat—UGCG—Metabolism—HSD17B1—prostate cancer	0.000921	0.00311	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	0.000921	0.00311	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	0.000908	0.00307	CbGpPWpGaD
Miglustat—GBA2—Metabolism—B4GALT4—prostate cancer	0.000897	0.00303	CbGpPWpGaD
Miglustat—GBA2—Metabolism—HPGD—prostate cancer	0.000897	0.00303	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	0.000885	0.00299	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	0.000881	0.00298	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	0.000872	0.00295	CbGpPWpGaD
Miglustat—GBA2—Metabolism—TNFRSF21—prostate cancer	0.000844	0.00285	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	0.000831	0.00281	CbGpPWpGaD
Miglustat—UGCG—Metabolism—HPGD—prostate cancer	0.000821	0.00277	CbGpPWpGaD
Miglustat—GBA2—Metabolism—MTAP—prostate cancer	0.000821	0.00277	CbGpPWpGaD
Miglustat—UGCG—Metabolism—B4GALT4—prostate cancer	0.000821	0.00277	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CYP7B1—prostate cancer	0.000821	0.00277	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	0.000802	0.00271	CbGpPWpGaD
Miglustat—GBA2—Metabolism—SRD5A1—prostate cancer	0.0008	0.0027	CbGpPWpGaD
Miglustat—GBA2—Metabolism—SULT1E1—prostate cancer	0.0008	0.0027	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	0.000777	0.00263	CbGpPWpGaD
Miglustat—UGCG—Metabolism—TNFRSF21—prostate cancer	0.000772	0.00261	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	0.000765	0.00259	CbGpPWpGaD
Miglustat—GBA2—Metabolism—ACSL4—prostate cancer	0.000763	0.00258	CbGpPWpGaD
Miglustat—GBA2—Metabolism—HSD17B3—prostate cancer	0.000763	0.00258	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	0.000754	0.00255	CbGpPWpGaD
Miglustat—UGCG—Metabolism—MTAP—prostate cancer	0.000751	0.00254	CbGpPWpGaD
Miglustat—UGCG—Metabolism—CYP7B1—prostate cancer	0.000751	0.00254	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	0.000734	0.00248	CbGpPWpGaD
Miglustat—UGCG—Metabolism—SULT1E1—prostate cancer	0.000731	0.00247	CbGpPWpGaD
Miglustat—UGCG—Metabolism—SRD5A1—prostate cancer	0.000731	0.00247	CbGpPWpGaD
Miglustat—GBA2—Metabolism—UMPS—prostate cancer	0.000731	0.00247	CbGpPWpGaD
Miglustat—GBA2—Metabolism—ARG2—prostate cancer	0.000731	0.00247	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PHGDH—prostate cancer	0.000731	0.00247	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	0.000728	0.00246	CbGpPWpGaD
Miglustat—GBA2—Metabolism—LDHB—prostate cancer	0.000717	0.00242	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	0.00071	0.0024	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CYP3A5—prostate cancer	0.000704	0.00238	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	0.0007	0.00237	CbGpPWpGaD
Miglustat—UGCG—Metabolism—ACSL4—prostate cancer	0.000698	0.00236	CbGpPWpGaD
Miglustat—UGCG—Metabolism—HSD17B3—prostate cancer	0.000698	0.00236	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	0.00069	0.00233	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PDHA1—prostate cancer	0.00068	0.0023	CbGpPWpGaD
Miglustat—GBA2—Metabolism—UCP3—prostate cancer	0.00068	0.0023	CbGpPWpGaD
Miglustat—GBA2—Metabolism—GSTA3—prostate cancer	0.00068	0.0023	CbGpPWpGaD
Miglustat—GBA2—Metabolism—TCN2—prostate cancer	0.00068	0.0023	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PHGDH—prostate cancer	0.000669	0.00226	CbGpPWpGaD
Miglustat—UGCG—Metabolism—ARG2—prostate cancer	0.000669	0.00226	CbGpPWpGaD
Miglustat—UGCG—Metabolism—UMPS—prostate cancer	0.000669	0.00226	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	0.000666	0.00225	CbGpPWpGaD
Miglustat—UGCG—Metabolism—LDHB—prostate cancer	0.000656	0.00222	CbGpPWpGaD
Miglustat—GBA2—Metabolism—HSD3B1—prostate cancer	0.000649	0.00219	CbGpPWpGaD
Miglustat—GBA2—Metabolism—SLC22A3—prostate cancer	0.000649	0.00219	CbGpPWpGaD
Miglustat—UGCG—Metabolism—CYP3A5—prostate cancer	0.000644	0.00218	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	0.000629	0.00213	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PDHA1—prostate cancer	0.000622	0.0021	CbGpPWpGaD
Miglustat—UGCG—Metabolism—GSTA3—prostate cancer	0.000622	0.0021	CbGpPWpGaD
Miglustat—GBA2—Metabolism—TBXAS1—prostate cancer	0.000622	0.0021	CbGpPWpGaD
Miglustat—UGCG—Metabolism—TCN2—prostate cancer	0.000622	0.0021	CbGpPWpGaD
Miglustat—UGCG—Metabolism—UCP3—prostate cancer	0.000622	0.0021	CbGpPWpGaD
Miglustat—GBA2—Metabolism—GSTA4—prostate cancer	0.000622	0.0021	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	0.000608	0.00205	CbGpPWpGaD
Miglustat—GBA2—Metabolism—GSTA2—prostate cancer	0.000606	0.00205	CbGpPWpGaD
Miglustat—GBA2—Metabolism—ABCG5—prostate cancer	0.000599	0.00202	CbGpPWpGaD
Miglustat—GBA2—Metabolism—SULT1A1—prostate cancer	0.000599	0.00202	CbGpPWpGaD
Miglustat—UGCG—Metabolism—HSD3B1—prostate cancer	0.000593	0.00201	CbGpPWpGaD
Miglustat—UGCG—Metabolism—SLC22A3—prostate cancer	0.000593	0.00201	CbGpPWpGaD
Miglustat—GBA2—Metabolism—GSTA1—prostate cancer	0.000585	0.00198	CbGpPWpGaD
Miglustat—GBA2—Metabolism—GSTO1—prostate cancer	0.000578	0.00195	CbGpPWpGaD
Miglustat—GBA2—Metabolism—HSD3B2—prostate cancer	0.000578	0.00195	CbGpPWpGaD
Miglustat—GBA2—Metabolism—NAT2—prostate cancer	0.000578	0.00195	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—LPL—prostate cancer	0.000576	0.00195	CbGpPWpGaD
Miglustat—UGCG—Metabolism—GSTA4—prostate cancer	0.000569	0.00192	CbGpPWpGaD
Miglustat—UGCG—Metabolism—TBXAS1—prostate cancer	0.000569	0.00192	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	0.000556	0.00188	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	0.000556	0.00188	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PLCB2—prostate cancer	0.000554	0.00187	CbGpPWpGaD
Miglustat—UGCG—Metabolism—GSTA2—prostate cancer	0.000554	0.00187	CbGpPWpGaD
Miglustat—GBA2—Metabolism—LRP2—prostate cancer	0.000554	0.00187	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CYP2C18—prostate cancer	0.000554	0.00187	CbGpPWpGaD
Miglustat—UGCG—Metabolism—SULT1A1—prostate cancer	0.000548	0.00185	CbGpPWpGaD
Miglustat—UGCG—Metabolism—ABCG5—prostate cancer	0.000548	0.00185	CbGpPWpGaD
Miglustat—GBA2—Metabolism—P4HB—prostate cancer	0.000544	0.00184	CbGpPWpGaD
Miglustat—UGCG—Metabolism—GSTA1—prostate cancer	0.000535	0.00181	CbGpPWpGaD
Miglustat—UGCG—Metabolism—HSD3B2—prostate cancer	0.000529	0.00179	CbGpPWpGaD
Miglustat—UGCG—Metabolism—GSTO1—prostate cancer	0.000529	0.00179	CbGpPWpGaD
Miglustat—GBA2—Metabolism—SLC22A1—prostate cancer	0.000529	0.00179	CbGpPWpGaD
Miglustat—UGCG—Metabolism—NAT2—prostate cancer	0.000529	0.00179	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	0.000523	0.00177	CbGpPWpGaD
Miglustat—GBA2—Metabolism—SULT2A1—prostate cancer	0.000515	0.00174	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	0.000508	0.00172	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PLCB2—prostate cancer	0.000507	0.00171	CbGpPWpGaD
Miglustat—UGCG—Metabolism—LRP2—prostate cancer	0.000507	0.00171	CbGpPWpGaD
Miglustat—UGCG—Metabolism—CYP2C18—prostate cancer	0.000507	0.00171	CbGpPWpGaD
Miglustat—GBA2—Metabolism—MED12—prostate cancer	0.000507	0.00171	CbGpPWpGaD
Miglustat—GBA2—Metabolism—GNG5—prostate cancer	0.000503	0.0017	CbGpPWpGaD
Miglustat—UGCG—Metabolism—P4HB—prostate cancer	0.000497	0.00168	CbGpPWpGaD
Miglustat—GBA2—Metabolism—NCOA3—prostate cancer	0.000485	0.00164	CbGpPWpGaD
Miglustat—UGCG—Metabolism—SLC22A1—prostate cancer	0.000484	0.00164	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	0.000478	0.00162	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	0.000476	0.00161	CbGpPWpGaD
Miglustat—UGCG—Metabolism—SULT2A1—prostate cancer	0.000471	0.00159	CbGpPWpGaD
Miglustat—UGCG—Metabolism—MED12—prostate cancer	0.000464	0.00157	CbGpPWpGaD
Miglustat—GBA2—Metabolism—HPGDS—prostate cancer	0.000462	0.00156	CbGpPWpGaD
Miglustat—UGCG—Metabolism—GNG5—prostate cancer	0.00046	0.00156	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CYP2C19—prostate cancer	0.000459	0.00155	CbGpPWpGaD
Miglustat—GBA2—Metabolism—ACHE—prostate cancer	0.000448	0.00152	CbGpPWpGaD
Miglustat—GBA2—Metabolism—GSTT1—prostate cancer	0.000448	0.00152	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CYP2A6—prostate cancer	0.000443	0.0015	CbGpPWpGaD
Miglustat—UGCG—Metabolism—NCOA3—prostate cancer	0.000443	0.0015	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	0.000441	0.00149	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	0.000435	0.00147	CbGpPWpGaD
Miglustat—GBA2—Metabolism—AKR1C3—prostate cancer	0.000431	0.00146	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PRKACB—prostate cancer	0.000429	0.00145	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CYP17A1—prostate cancer	0.000424	0.00143	CbGpPWpGaD
Miglustat—UGCG—Metabolism—HPGDS—prostate cancer	0.000423	0.00143	CbGpPWpGaD
Miglustat—UGCG—Metabolism—CYP2C19—prostate cancer	0.00042	0.00142	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	0.000419	0.00141	CbGpPWpGaD
Miglustat—UGCG—Metabolism—GSTT1—prostate cancer	0.00041	0.00139	CbGpPWpGaD
Miglustat—UGCG—Metabolism—ACHE—prostate cancer	0.00041	0.00139	CbGpPWpGaD
Miglustat—UGCG—Metabolism—CYP2A6—prostate cancer	0.000405	0.00137	CbGpPWpGaD
Miglustat—GBA2—Metabolism—NCOA2—prostate cancer	0.000404	0.00137	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	0.000404	0.00136	CbGpPWpGaD
Miglustat—UGCG—Metabolism—AKR1C3—prostate cancer	0.000394	0.00133	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PRKACB—prostate cancer	0.000392	0.00133	CbGpPWpGaD
Miglustat—UGCG—Metabolism—CYP17A1—prostate cancer	0.000388	0.00131	CbGpPWpGaD
Miglustat—GBA2—Metabolism—SLC5A5—prostate cancer	0.000386	0.0013	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	0.000383	0.00129	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CYP2E1—prostate cancer	0.000377	0.00127	CbGpPWpGaD
Miglustat—GBA2—Metabolism—NQO1—prostate cancer	0.000373	0.00126	CbGpPWpGaD
Miglustat—UGCG—Metabolism—NCOA2—prostate cancer	0.00037	0.00125	CbGpPWpGaD
Miglustat—GBA2—Metabolism—TH—prostate cancer	0.000367	0.00124	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	0.000365	0.00123	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CYP3A4—prostate cancer	0.000363	0.00123	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	0.000362	0.00122	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CYP1B1—prostate cancer	0.000357	0.00121	CbGpPWpGaD
Miglustat—UGCG—Metabolism—SLC5A5—prostate cancer	0.000353	0.00119	CbGpPWpGaD
Miglustat—Ill-defined disorder—Etoposide—prostate cancer	0.000347	0.000709	CcSEcCtD
Miglustat—Dyspepsia—Estradiol—prostate cancer	0.000347	0.000709	CcSEcCtD
Miglustat—GBA2—Metabolism—GGT1—prostate cancer	0.000346	0.00117	CbGpPWpGaD
Miglustat—Haemorrhage—Capecitabine—prostate cancer	0.000346	0.000707	CcSEcCtD
Miglustat—UGCG—Metabolism—CYP2E1—prostate cancer	0.000345	0.00117	CbGpPWpGaD
Miglustat—Visual impairment—Docetaxel—prostate cancer	0.000344	0.000703	CcSEcCtD
Miglustat—Hypoaesthesia—Capecitabine—prostate cancer	0.000344	0.000703	CcSEcCtD
Miglustat—Migraine—Epirubicin—prostate cancer	0.000343	0.000701	CcSEcCtD
Miglustat—Decreased appetite—Estradiol—prostate cancer	0.000342	0.0007	CcSEcCtD
Miglustat—Depression—Prednisone—prostate cancer	0.000342	0.000699	CcSEcCtD
Miglustat—GBA2—Metabolism—NCOA1—prostate cancer	0.000341	0.00115	CbGpPWpGaD
Miglustat—UGCG—Metabolism—NQO1—prostate cancer	0.000341	0.00115	CbGpPWpGaD
Miglustat—Gastrointestinal disorder—Estradiol—prostate cancer	0.00034	0.000695	CcSEcCtD
Miglustat—Diarrhoea—Goserelin—prostate cancer	0.00034	0.000695	CcSEcCtD
Miglustat—Connective tissue disorder—Capecitabine—prostate cancer	0.00034	0.000694	CcSEcCtD
Miglustat—Fatigue—Estradiol—prostate cancer	0.00034	0.000694	CcSEcCtD
Miglustat—Malaise—Etoposide—prostate cancer	0.000337	0.00069	CcSEcCtD
Miglustat—Constipation—Estradiol—prostate cancer	0.000337	0.000689	CcSEcCtD
Miglustat—Pain—Estradiol—prostate cancer	0.000337	0.000689	CcSEcCtD
Miglustat—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000337	0.000688	CcSEcCtD
Miglustat—Neuropathy peripheral—Prednisone—prostate cancer	0.000336	0.000687	CcSEcCtD
Miglustat—Vertigo—Etoposide—prostate cancer	0.000336	0.000687	CcSEcCtD
Miglustat—UGCG—Metabolism—TH—prostate cancer	0.000336	0.00114	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CYP19A1—prostate cancer	0.000336	0.00114	CbGpPWpGaD
Miglustat—Eye disorder—Docetaxel—prostate cancer	0.000334	0.000682	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	0.000334	0.00113	CbGpPWpGaD
Miglustat—Visual impairment—Capecitabine—prostate cancer	0.000333	0.000681	CcSEcCtD
Miglustat—UGCG—Metabolism—CYP3A4—prostate cancer	0.000332	0.00112	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	0.000331	0.00112	CbGpPWpGaD
Miglustat—Paraesthesia—Mitoxantrone—prostate cancer	0.00033	0.000674	CcSEcCtD
Miglustat—Dizziness—Goserelin—prostate cancer	0.000329	0.000672	CcSEcCtD
Miglustat—Ataxia—Epirubicin—prostate cancer	0.000327	0.000669	CcSEcCtD
Miglustat—UGCG—Metabolism—CYP1B1—prostate cancer	0.000327	0.0011	CbGpPWpGaD
Miglustat—Dizziness—Conjugated Estrogens—prostate cancer	0.000326	0.000665	CcSEcCtD
Miglustat—Feeling abnormal—Estradiol—prostate cancer	0.000325	0.000663	CcSEcCtD
Miglustat—Convulsion—Etoposide—prostate cancer	0.000324	0.000662	CcSEcCtD
Miglustat—GBA2—Metabolism—RXRA—prostate cancer	0.000324	0.0011	CbGpPWpGaD
Miglustat—Eye disorder—Capecitabine—prostate cancer	0.000323	0.00066	CcSEcCtD
Miglustat—Dyspepsia—Mitoxantrone—prostate cancer	0.000323	0.00066	CcSEcCtD
Miglustat—Pain in extremity—Doxorubicin—prostate cancer	0.000322	0.000659	CcSEcCtD
Miglustat—Gastrointestinal pain—Estradiol—prostate cancer	0.000322	0.000658	CcSEcCtD
Miglustat—Chills—Docetaxel—prostate cancer	0.000321	0.000655	CcSEcCtD
Miglustat—Decreased appetite—Mitoxantrone—prostate cancer	0.000319	0.000652	CcSEcCtD
Miglustat—Abdominal pain upper—Epirubicin—prostate cancer	0.000318	0.00065	CcSEcCtD
Miglustat—Migraine—Doxorubicin—prostate cancer	0.000317	0.000648	CcSEcCtD
Miglustat—Fatigue—Mitoxantrone—prostate cancer	0.000317	0.000647	CcSEcCtD
Miglustat—UGCG—Metabolism—GGT1—prostate cancer	0.000316	0.00107	CbGpPWpGaD
Miglustat—Vomiting—Goserelin—prostate cancer	0.000316	0.000646	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	0.000315	0.00107	CbGpPWpGaD
Miglustat—Discomfort—Etoposide—prostate cancer	0.000315	0.000643	CcSEcCtD
Miglustat—Constipation—Mitoxantrone—prostate cancer	0.000314	0.000642	CcSEcCtD
Miglustat—Pain—Mitoxantrone—prostate cancer	0.000314	0.000642	CcSEcCtD
Miglustat—Vomiting—Conjugated Estrogens—prostate cancer	0.000313	0.00064	CcSEcCtD
Miglustat—Mental disorder—Docetaxel—prostate cancer	0.000313	0.00064	CcSEcCtD
Miglustat—GBA2—Metabolism—COMT—prostate cancer	0.000312	0.00106	CbGpPWpGaD
Miglustat—UGCG—Metabolism—NCOA1—prostate cancer	0.000312	0.00105	CbGpPWpGaD
Miglustat—Abdominal pain—Estradiol—prostate cancer	0.000311	0.000636	CcSEcCtD
Miglustat—Headache—Goserelin—prostate cancer	0.000311	0.000636	CcSEcCtD
Miglustat—Malnutrition—Docetaxel—prostate cancer	0.000311	0.000635	CcSEcCtD
Miglustat—GBA2—Metabolism—GSTP1—prostate cancer	0.000311	0.00105	CbGpPWpGaD
Miglustat—Chills—Capecitabine—prostate cancer	0.00031	0.000634	CcSEcCtD
Miglustat—Haemoglobin—Prednisone—prostate cancer	0.00031	0.000633	CcSEcCtD
Miglustat—Headache—Conjugated Estrogens—prostate cancer	0.000308	0.00063	CcSEcCtD
Miglustat—Haemorrhage—Prednisone—prostate cancer	0.000308	0.00063	CcSEcCtD
Miglustat—UGCG—Metabolism—CYP19A1—prostate cancer	0.000307	0.00104	CbGpPWpGaD
Miglustat—Muscular weakness—Epirubicin—prostate cancer	0.000307	0.000628	CcSEcCtD
Miglustat—GBA2—Metabolism—ITPR1—prostate cancer	0.000306	0.00103	CbGpPWpGaD
Miglustat—Abdominal distension—Epirubicin—prostate cancer	0.000303	0.000619	CcSEcCtD
Miglustat—Ataxia—Doxorubicin—prostate cancer	0.000303	0.000619	CcSEcCtD
Miglustat—Mental disorder—Capecitabine—prostate cancer	0.000303	0.000619	CcSEcCtD
Miglustat—Connective tissue disorder—Prednisone—prostate cancer	0.000303	0.000619	CcSEcCtD
Miglustat—Feeling abnormal—Mitoxantrone—prostate cancer	0.000303	0.000618	CcSEcCtD
Miglustat—Malnutrition—Capecitabine—prostate cancer	0.000301	0.000615	CcSEcCtD
Miglustat—Back pain—Docetaxel—prostate cancer	0.000301	0.000615	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	0.000301	0.00102	CbGpPWpGaD
Miglustat—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.0003	0.000613	CcSEcCtD
Miglustat—Thrombocytopenia—Etoposide—prostate cancer	0.000299	0.000611	CcSEcCtD
Miglustat—Muscle spasms—Docetaxel—prostate cancer	0.000299	0.000611	CcSEcCtD
Miglustat—Flatulence—Capecitabine—prostate cancer	0.000297	0.000606	CcSEcCtD
Miglustat—UGCG—Metabolism—RXRA—prostate cancer	0.000296	0.001	CbGpPWpGaD
Miglustat—Nausea—Goserelin—prostate cancer	0.000295	0.000603	CcSEcCtD
Miglustat—Abdominal pain upper—Doxorubicin—prostate cancer	0.000294	0.000601	CcSEcCtD
Miglustat—Nausea—Conjugated Estrogens—prostate cancer	0.000292	0.000598	CcSEcCtD
Miglustat—Back pain—Capecitabine—prostate cancer	0.000291	0.000595	CcSEcCtD
Miglustat—Anorexia—Etoposide—prostate cancer	0.000291	0.000595	CcSEcCtD
Miglustat—Abdominal pain—Mitoxantrone—prostate cancer	0.00029	0.000593	CcSEcCtD
Miglustat—Muscle spasms—Capecitabine—prostate cancer	0.000289	0.000591	CcSEcCtD
Miglustat—GBA2—Metabolism—TYMS—prostate cancer	0.000289	0.000977	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	0.000288	0.000975	CbGpPWpGaD
Miglustat—Eye disorder—Prednisone—prostate cancer	0.000288	0.000588	CcSEcCtD
Miglustat—GBA2—Metabolism—GSTM1—prostate cancer	0.000286	0.000965	CbGpPWpGaD
Miglustat—UGCG—Metabolism—COMT—prostate cancer	0.000286	0.000965	CbGpPWpGaD
Miglustat—UGCG—Metabolism—GSTP1—prostate cancer	0.000284	0.000961	CbGpPWpGaD
Miglustat—Muscular weakness—Doxorubicin—prostate cancer	0.000284	0.000581	CcSEcCtD
Miglustat—Asthenia—Estradiol—prostate cancer	0.000283	0.000578	CcSEcCtD
Miglustat—Tremor—Capecitabine—prostate cancer	0.000282	0.000576	CcSEcCtD
Miglustat—Abdominal distension—Doxorubicin—prostate cancer	0.00028	0.000573	CcSEcCtD
Miglustat—GBA2—Metabolism—LPL—prostate cancer	0.00028	0.000948	CbGpPWpGaD
Miglustat—UGCG—Metabolism—ITPR1—prostate cancer	0.00028	0.000945	CbGpPWpGaD
Miglustat—Ill-defined disorder—Capecitabine—prostate cancer	0.000279	0.000571	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—EP300—prostate cancer	0.000275	0.00093	CbGpPWpGaD
Miglustat—Paraesthesia—Etoposide—prostate cancer	0.000274	0.00056	CcSEcCtD
Miglustat—Weight decreased—Epirubicin—prostate cancer	0.000272	0.000557	CcSEcCtD
Miglustat—Malaise—Capecitabine—prostate cancer	0.000271	0.000555	CcSEcCtD
Miglustat—GBA2—Metabolism—CYP1A1—prostate cancer	0.000271	0.000915	CbGpPWpGaD
Miglustat—Vertigo—Capecitabine—prostate cancer	0.00027	0.000553	CcSEcCtD
Miglustat—Mental disorder—Prednisone—prostate cancer	0.00027	0.000552	CcSEcCtD
Miglustat—Diarrhoea—Estradiol—prostate cancer	0.00027	0.000551	CcSEcCtD
Miglustat—Convulsion—Docetaxel—prostate cancer	0.000269	0.000551	CcSEcCtD
Miglustat—GBA2—Metabolism—ERCC2—prostate cancer	0.000268	0.000908	CbGpPWpGaD
Miglustat—Malnutrition—Prednisone—prostate cancer	0.000268	0.000548	CcSEcCtD
Miglustat—Decreased appetite—Etoposide—prostate cancer	0.000265	0.000542	CcSEcCtD
Miglustat—UGCG—Metabolism—TYMS—prostate cancer	0.000264	0.000893	CbGpPWpGaD
Miglustat—Gastrointestinal disorder—Etoposide—prostate cancer	0.000264	0.000539	CcSEcCtD
Miglustat—Asthenia—Mitoxantrone—prostate cancer	0.000263	0.000538	CcSEcCtD
Miglustat—Fatigue—Etoposide—prostate cancer	0.000263	0.000538	CcSEcCtD
Miglustat—Neuropathy peripheral—Epirubicin—prostate cancer	0.000263	0.000538	CcSEcCtD
Miglustat—UGCG—Metabolism—GSTM1—prostate cancer	0.000261	0.000883	CbGpPWpGaD
Miglustat—Constipation—Etoposide—prostate cancer	0.000261	0.000534	CcSEcCtD
Miglustat—Pain—Etoposide—prostate cancer	0.000261	0.000534	CcSEcCtD
Miglustat—Dizziness—Estradiol—prostate cancer	0.000261	0.000532	CcSEcCtD
Miglustat—Dry mouth—Docetaxel—prostate cancer	0.000259	0.000529	CcSEcCtD
Miglustat—UGCG—Metabolism—LPL—prostate cancer	0.000256	0.000867	CbGpPWpGaD
Miglustat—Discomfort—Capecitabine—prostate cancer	0.000253	0.000517	CcSEcCtD
Miglustat—GBA2—Metabolism—MTHFR—prostate cancer	0.000252	0.000853	CbGpPWpGaD
Miglustat—Weight decreased—Doxorubicin—prostate cancer	0.000252	0.000515	CcSEcCtD
Miglustat—Feeling abnormal—Etoposide—prostate cancer	0.000252	0.000514	CcSEcCtD
Miglustat—Diarrhoea—Mitoxantrone—prostate cancer	0.000251	0.000513	CcSEcCtD
Miglustat—Dry mouth—Capecitabine—prostate cancer	0.000251	0.000512	CcSEcCtD
Miglustat—Vomiting—Estradiol—prostate cancer	0.000251	0.000512	CcSEcCtD
Miglustat—Gastrointestinal pain—Etoposide—prostate cancer	0.00025	0.00051	CcSEcCtD
Miglustat—Nervous system disorder—Docetaxel—prostate cancer	0.000249	0.000509	CcSEcCtD
Miglustat—Ill-defined disorder—Prednisone—prostate cancer	0.000249	0.000508	CcSEcCtD
Miglustat—Thrombocytopenia—Docetaxel—prostate cancer	0.000248	0.000508	CcSEcCtD
Miglustat—UGCG—Metabolism—CYP1A1—prostate cancer	0.000248	0.000837	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PPARA—prostate cancer	0.000248	0.000837	CbGpPWpGaD
Miglustat—Headache—Estradiol—prostate cancer	0.000247	0.000504	CcSEcCtD
Miglustat—UGCG—Metabolism—ERCC2—prostate cancer	0.000246	0.00083	CbGpPWpGaD
Miglustat—Neuropathy peripheral—Doxorubicin—prostate cancer	0.000243	0.000497	CcSEcCtD
Miglustat—Haemoglobin—Epirubicin—prostate cancer	0.000242	0.000495	CcSEcCtD
Miglustat—Anorexia—Docetaxel—prostate cancer	0.000242	0.000494	CcSEcCtD
Miglustat—Malaise—Prednisone—prostate cancer	0.000242	0.000494	CcSEcCtD
Miglustat—Abdominal pain—Etoposide—prostate cancer	0.000241	0.000493	CcSEcCtD
Miglustat—Nervous system disorder—Capecitabine—prostate cancer	0.000241	0.000492	CcSEcCtD
Miglustat—Vertigo—Prednisone—prostate cancer	0.000241	0.000492	CcSEcCtD
Miglustat—Haemorrhage—Epirubicin—prostate cancer	0.000241	0.000492	CcSEcCtD
Miglustat—Thrombocytopenia—Capecitabine—prostate cancer	0.000241	0.000492	CcSEcCtD
Miglustat—Hypoaesthesia—Epirubicin—prostate cancer	0.00024	0.00049	CcSEcCtD
Miglustat—Connective tissue disorder—Epirubicin—prostate cancer	0.000237	0.000484	CcSEcCtD
Miglustat—Anorexia—Capecitabine—prostate cancer	0.000234	0.000479	CcSEcCtD
Miglustat—Nausea—Estradiol—prostate cancer	0.000234	0.000478	CcSEcCtD
Miglustat—Vomiting—Mitoxantrone—prostate cancer	0.000233	0.000477	CcSEcCtD
Miglustat—GBA2—Metabolism—CAV1—prostate cancer	0.000233	0.000787	CbGpPWpGaD
Miglustat—Convulsion—Prednisone—prostate cancer	0.000232	0.000475	CcSEcCtD
Miglustat—Visual impairment—Epirubicin—prostate cancer	0.000232	0.000474	CcSEcCtD
Miglustat—UGCG—Metabolism—MTHFR—prostate cancer	0.000231	0.00078	CbGpPWpGaD
Miglustat—Headache—Mitoxantrone—prostate cancer	0.00023	0.00047	CcSEcCtD
Miglustat—Insomnia—Docetaxel—prostate cancer	0.00023	0.000469	CcSEcCtD
Miglustat—Paraesthesia—Docetaxel—prostate cancer	0.000228	0.000466	CcSEcCtD
Miglustat—UGCG—Metabolism—PPARA—prostate cancer	0.000226	0.000766	CbGpPWpGaD
Miglustat—Discomfort—Prednisone—prostate cancer	0.000226	0.000461	CcSEcCtD
Miglustat—Eye disorder—Epirubicin—prostate cancer	0.000225	0.00046	CcSEcCtD
Miglustat—Haemoglobin—Doxorubicin—prostate cancer	0.000224	0.000458	CcSEcCtD
Miglustat—Dyspepsia—Docetaxel—prostate cancer	0.000223	0.000457	CcSEcCtD
Miglustat—Haemorrhage—Doxorubicin—prostate cancer	0.000223	0.000456	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	0.000222	0.000752	CbGpPWpGaD
Miglustat—Insomnia—Capecitabine—prostate cancer	0.000222	0.000454	CcSEcCtD
Miglustat—Hypoaesthesia—Doxorubicin—prostate cancer	0.000222	0.000453	CcSEcCtD
Miglustat—Paraesthesia—Capecitabine—prostate cancer	0.000221	0.000451	CcSEcCtD
Miglustat—Decreased appetite—Docetaxel—prostate cancer	0.000221	0.000451	CcSEcCtD
Miglustat—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000219	0.000448	CcSEcCtD
Miglustat—Asthenia—Etoposide—prostate cancer	0.000219	0.000448	CcSEcCtD
Miglustat—Connective tissue disorder—Doxorubicin—prostate cancer	0.000219	0.000448	CcSEcCtD
Miglustat—Fatigue—Docetaxel—prostate cancer	0.000219	0.000447	CcSEcCtD
Miglustat—Nausea—Mitoxantrone—prostate cancer	0.000218	0.000446	CcSEcCtD
Miglustat—Constipation—Docetaxel—prostate cancer	0.000217	0.000443	CcSEcCtD
Miglustat—Pain—Docetaxel—prostate cancer	0.000217	0.000443	CcSEcCtD
Miglustat—Dyspepsia—Capecitabine—prostate cancer	0.000216	0.000442	CcSEcCtD
Miglustat—Chills—Epirubicin—prostate cancer	0.000216	0.000442	CcSEcCtD
Miglustat—Visual impairment—Doxorubicin—prostate cancer	0.000215	0.000439	CcSEcCtD
Miglustat—Nervous system disorder—Prednisone—prostate cancer	0.000215	0.000439	CcSEcCtD
Miglustat—Decreased appetite—Capecitabine—prostate cancer	0.000214	0.000436	CcSEcCtD
Miglustat—UGCG—Metabolism—CAV1—prostate cancer	0.000213	0.00072	CbGpPWpGaD
Miglustat—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000212	0.000433	CcSEcCtD
Miglustat—GBA2—Metabolism—PIK3CG—prostate cancer	0.000212	0.000717	CbGpPWpGaD
Miglustat—Fatigue—Capecitabine—prostate cancer	0.000212	0.000433	CcSEcCtD
Miglustat—Mental disorder—Epirubicin—prostate cancer	0.000211	0.000431	CcSEcCtD
Miglustat—Pain—Capecitabine—prostate cancer	0.00021	0.000429	CcSEcCtD
Miglustat—Constipation—Capecitabine—prostate cancer	0.00021	0.000429	CcSEcCtD
Miglustat—Malnutrition—Epirubicin—prostate cancer	0.00021	0.000429	CcSEcCtD
Miglustat—Feeling abnormal—Docetaxel—prostate cancer	0.000209	0.000427	CcSEcCtD
Miglustat—Diarrhoea—Etoposide—prostate cancer	0.000209	0.000427	CcSEcCtD
Miglustat—Anorexia—Prednisone—prostate cancer	0.000209	0.000426	CcSEcCtD
Miglustat—Eye disorder—Doxorubicin—prostate cancer	0.000208	0.000426	CcSEcCtD
Miglustat—Gastrointestinal pain—Docetaxel—prostate cancer	0.000208	0.000424	CcSEcCtD
Miglustat—Flatulence—Epirubicin—prostate cancer	0.000207	0.000422	CcSEcCtD
Miglustat—Nervousness—Epirubicin—prostate cancer	0.000204	0.000416	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	0.000203	0.000688	CbGpPWpGaD
Miglustat—Back pain—Epirubicin—prostate cancer	0.000203	0.000415	CcSEcCtD
Miglustat—Feeling abnormal—Capecitabine—prostate cancer	0.000202	0.000414	CcSEcCtD
Miglustat—Dizziness—Etoposide—prostate cancer	0.000202	0.000413	CcSEcCtD
Miglustat—Muscle spasms—Epirubicin—prostate cancer	0.000202	0.000412	CcSEcCtD
Miglustat—Gastrointestinal pain—Capecitabine—prostate cancer	0.000201	0.000411	CcSEcCtD
Miglustat—GBA2—Metabolism—INS—prostate cancer	0.000201	0.000679	CbGpPWpGaD
Miglustat—Abdominal pain—Docetaxel—prostate cancer	0.000201	0.00041	CcSEcCtD
Miglustat—Chills—Doxorubicin—prostate cancer	0.0002	0.000409	CcSEcCtD
Miglustat—Insomnia—Prednisone—prostate cancer	0.000198	0.000405	CcSEcCtD
Miglustat—GBA2—Metabolism—CREBBP—prostate cancer	0.000197	0.000665	CbGpPWpGaD
Miglustat—Paraesthesia—Prednisone—prostate cancer	0.000197	0.000402	CcSEcCtD
Miglustat—Mental disorder—Doxorubicin—prostate cancer	0.000195	0.000399	CcSEcCtD
Miglustat—Ill-defined disorder—Epirubicin—prostate cancer	0.000195	0.000398	CcSEcCtD
Miglustat—Abdominal pain—Capecitabine—prostate cancer	0.000194	0.000397	CcSEcCtD
Miglustat—Vomiting—Etoposide—prostate cancer	0.000194	0.000397	CcSEcCtD
Miglustat—Malnutrition—Doxorubicin—prostate cancer	0.000194	0.000397	CcSEcCtD
Miglustat—UGCG—Metabolism—PIK3CG—prostate cancer	0.000194	0.000656	CbGpPWpGaD
Miglustat—Dyspepsia—Prednisone—prostate cancer	0.000193	0.000394	CcSEcCtD
Miglustat—Headache—Etoposide—prostate cancer	0.000191	0.000391	CcSEcCtD
Miglustat—Flatulence—Doxorubicin—prostate cancer	0.000191	0.000391	CcSEcCtD
Miglustat—Decreased appetite—Prednisone—prostate cancer	0.00019	0.000389	CcSEcCtD
Miglustat—Malaise—Epirubicin—prostate cancer	0.000189	0.000387	CcSEcCtD
Miglustat—Fatigue—Prednisone—prostate cancer	0.000189	0.000386	CcSEcCtD
Miglustat—Nervousness—Doxorubicin—prostate cancer	0.000188	0.000385	CcSEcCtD
Miglustat—Vertigo—Epirubicin—prostate cancer	0.000188	0.000385	CcSEcCtD
Miglustat—Back pain—Doxorubicin—prostate cancer	0.000188	0.000384	CcSEcCtD
Miglustat—Constipation—Prednisone—prostate cancer	0.000187	0.000382	CcSEcCtD
Miglustat—Muscle spasms—Doxorubicin—prostate cancer	0.000187	0.000381	CcSEcCtD
Miglustat—GBA2—Metabolism—PIK3CD—prostate cancer	0.000186	0.00063	CbGpPWpGaD
Miglustat—UGCG—Metabolism—INS—prostate cancer	0.000184	0.000621	CbGpPWpGaD
Miglustat—Asthenia—Docetaxel—prostate cancer	0.000182	0.000372	CcSEcCtD
Miglustat—Convulsion—Epirubicin—prostate cancer	0.000182	0.000371	CcSEcCtD
Miglustat—Nausea—Etoposide—prostate cancer	0.000181	0.000371	CcSEcCtD
Miglustat—Feeling abnormal—Prednisone—prostate cancer	0.00018	0.000369	CcSEcCtD
Miglustat—Ill-defined disorder—Doxorubicin—prostate cancer	0.00018	0.000368	CcSEcCtD
Miglustat—UGCG—Metabolism—CREBBP—prostate cancer	0.00018	0.000608	CbGpPWpGaD
Miglustat—Gastrointestinal pain—Prednisone—prostate cancer	0.000179	0.000366	CcSEcCtD
Miglustat—Discomfort—Epirubicin—prostate cancer	0.000176	0.000361	CcSEcCtD
Miglustat—Asthenia—Capecitabine—prostate cancer	0.000176	0.00036	CcSEcCtD
Miglustat—GBA2—Metabolism—NOS3—prostate cancer	0.000176	0.000595	CbGpPWpGaD
Miglustat—Malaise—Doxorubicin—prostate cancer	0.000175	0.000358	CcSEcCtD
Miglustat—Dry mouth—Epirubicin—prostate cancer	0.000175	0.000357	CcSEcCtD
Miglustat—Vertigo—Doxorubicin—prostate cancer	0.000174	0.000356	CcSEcCtD
Miglustat—Diarrhoea—Docetaxel—prostate cancer	0.000174	0.000355	CcSEcCtD
Miglustat—Abdominal pain—Prednisone—prostate cancer	0.000173	0.000354	CcSEcCtD
Miglustat—UGCG—Metabolism—PIK3CD—prostate cancer	0.00017	0.000576	CbGpPWpGaD
Miglustat—Convulsion—Doxorubicin—prostate cancer	0.000168	0.000344	CcSEcCtD
Miglustat—Diarrhoea—Capecitabine—prostate cancer	0.000168	0.000344	CcSEcCtD
Miglustat—Nervous system disorder—Epirubicin—prostate cancer	0.000168	0.000343	CcSEcCtD
Miglustat—Dizziness—Docetaxel—prostate cancer	0.000168	0.000343	CcSEcCtD
Miglustat—Thrombocytopenia—Epirubicin—prostate cancer	0.000168	0.000342	CcSEcCtD
Miglustat—Discomfort—Doxorubicin—prostate cancer	0.000163	0.000334	CcSEcCtD
Miglustat—Anorexia—Epirubicin—prostate cancer	0.000163	0.000333	CcSEcCtD
Miglustat—GBA2—Metabolism—PIK3CB—prostate cancer	0.000162	0.000549	CbGpPWpGaD
Miglustat—Dizziness—Capecitabine—prostate cancer	0.000162	0.000332	CcSEcCtD
Miglustat—Dry mouth—Doxorubicin—prostate cancer	0.000162	0.00033	CcSEcCtD
Miglustat—Vomiting—Docetaxel—prostate cancer	0.000161	0.00033	CcSEcCtD
Miglustat—UGCG—Metabolism—NOS3—prostate cancer	0.000161	0.000544	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PTGS2—prostate cancer	0.000161	0.000544	CbGpPWpGaD
Miglustat—Headache—Docetaxel—prostate cancer	0.000159	0.000325	CcSEcCtD
Miglustat—Asthenia—Prednisone—prostate cancer	0.000157	0.000321	CcSEcCtD
Miglustat—Vomiting—Capecitabine—prostate cancer	0.000156	0.000319	CcSEcCtD
Miglustat—Nervous system disorder—Doxorubicin—prostate cancer	0.000155	0.000317	CcSEcCtD
Miglustat—Thrombocytopenia—Doxorubicin—prostate cancer	0.000155	0.000317	CcSEcCtD
Miglustat—Insomnia—Epirubicin—prostate cancer	0.000155	0.000316	CcSEcCtD
Miglustat—Headache—Capecitabine—prostate cancer	0.000154	0.000315	CcSEcCtD
Miglustat—Paraesthesia—Epirubicin—prostate cancer	0.000154	0.000314	CcSEcCtD
Miglustat—Anorexia—Doxorubicin—prostate cancer	0.000151	0.000309	CcSEcCtD
Miglustat—Nausea—Docetaxel—prostate cancer	0.000151	0.000308	CcSEcCtD
Miglustat—Dyspepsia—Epirubicin—prostate cancer	0.000151	0.000308	CcSEcCtD
Miglustat—Diarrhoea—Prednisone—prostate cancer	0.00015	0.000306	CcSEcCtD
Miglustat—Decreased appetite—Epirubicin—prostate cancer	0.000149	0.000304	CcSEcCtD
Miglustat—UGCG—Metabolism—PIK3CB—prostate cancer	0.000149	0.000502	CbGpPWpGaD
Miglustat—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000148	0.000302	CcSEcCtD
Miglustat—Fatigue—Epirubicin—prostate cancer	0.000148	0.000302	CcSEcCtD
Miglustat—UGCG—Metabolism—PTGS2—prostate cancer	0.000147	0.000498	CbGpPWpGaD
Miglustat—Constipation—Epirubicin—prostate cancer	0.000146	0.000299	CcSEcCtD
Miglustat—Pain—Epirubicin—prostate cancer	0.000146	0.000299	CcSEcCtD
Miglustat—Nausea—Capecitabine—prostate cancer	0.000146	0.000298	CcSEcCtD
Miglustat—Dizziness—Prednisone—prostate cancer	0.000145	0.000296	CcSEcCtD
Miglustat—Insomnia—Doxorubicin—prostate cancer	0.000143	0.000293	CcSEcCtD
Miglustat—Paraesthesia—Doxorubicin—prostate cancer	0.000142	0.000291	CcSEcCtD
Miglustat—Feeling abnormal—Epirubicin—prostate cancer	0.000141	0.000288	CcSEcCtD
Miglustat—GBA2—Metabolism—PTEN—prostate cancer	0.00014	0.000475	CbGpPWpGaD
Miglustat—Gastrointestinal pain—Epirubicin—prostate cancer	0.00014	0.000286	CcSEcCtD
Miglustat—Dyspepsia—Doxorubicin—prostate cancer	0.000139	0.000285	CcSEcCtD
Miglustat—Vomiting—Prednisone—prostate cancer	0.000139	0.000284	CcSEcCtD
Miglustat—Decreased appetite—Doxorubicin—prostate cancer	0.000138	0.000281	CcSEcCtD
Miglustat—Headache—Prednisone—prostate cancer	0.000137	0.00028	CcSEcCtD
Miglustat—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000137	0.000279	CcSEcCtD
Miglustat—Fatigue—Doxorubicin—prostate cancer	0.000137	0.000279	CcSEcCtD
Miglustat—Constipation—Doxorubicin—prostate cancer	0.000135	0.000277	CcSEcCtD
Miglustat—Pain—Doxorubicin—prostate cancer	0.000135	0.000277	CcSEcCtD
Miglustat—Abdominal pain—Epirubicin—prostate cancer	0.000135	0.000277	CcSEcCtD
Miglustat—GBA2—Metabolism—EP300—prostate cancer	0.000134	0.000453	CbGpPWpGaD
Miglustat—Feeling abnormal—Doxorubicin—prostate cancer	0.000131	0.000267	CcSEcCtD
Miglustat—Nausea—Prednisone—prostate cancer	0.00013	0.000266	CcSEcCtD
Miglustat—Gastrointestinal pain—Doxorubicin—prostate cancer	0.00013	0.000265	CcSEcCtD
Miglustat—UGCG—Metabolism—PTEN—prostate cancer	0.000128	0.000434	CbGpPWpGaD
Miglustat—Abdominal pain—Doxorubicin—prostate cancer	0.000125	0.000256	CcSEcCtD
Miglustat—Asthenia—Epirubicin—prostate cancer	0.000123	0.000251	CcSEcCtD
Miglustat—UGCG—Metabolism—EP300—prostate cancer	0.000122	0.000414	CbGpPWpGaD
Miglustat—Diarrhoea—Epirubicin—prostate cancer	0.000117	0.000239	CcSEcCtD
Miglustat—Asthenia—Doxorubicin—prostate cancer	0.000114	0.000232	CcSEcCtD
Miglustat—Dizziness—Epirubicin—prostate cancer	0.000113	0.000231	CcSEcCtD
Miglustat—Vomiting—Epirubicin—prostate cancer	0.000109	0.000222	CcSEcCtD
Miglustat—Diarrhoea—Doxorubicin—prostate cancer	0.000108	0.000221	CcSEcCtD
Miglustat—Headache—Epirubicin—prostate cancer	0.000107	0.000219	CcSEcCtD
Miglustat—Dizziness—Doxorubicin—prostate cancer	0.000105	0.000214	CcSEcCtD
Miglustat—Nausea—Epirubicin—prostate cancer	0.000102	0.000208	CcSEcCtD
Miglustat—Vomiting—Doxorubicin—prostate cancer	0.000101	0.000206	CcSEcCtD
Miglustat—Headache—Doxorubicin—prostate cancer	9.92e-05	0.000203	CcSEcCtD
Miglustat—GBA2—Metabolism—PIK3CA—prostate cancer	9.9e-05	0.000335	CbGpPWpGaD
Miglustat—Nausea—Doxorubicin—prostate cancer	9.41e-05	0.000192	CcSEcCtD
Miglustat—UGCG—Metabolism—PIK3CA—prostate cancer	9.06e-05	0.000306	CbGpPWpGaD
Miglustat—GBA2—Metabolism—AKT1—prostate cancer	8.09e-05	0.000274	CbGpPWpGaD
Miglustat—UGCG—Metabolism—AKT1—prostate cancer	7.4e-05	0.00025	CbGpPWpGaD
